Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kraig Biocraft Laboratories Inc (OP: KBLB )

0.0925 +0.0001 (+0.11%)
Streaming Delayed Price Updated: 11:33 AM EDT, Sep 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 358,391
Open 0.0924
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0924
Today's Range 0.0866 - 0.0925
52wk Range 0.0250 - 0.1575
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Kraig Biocraft Laboratories Shares Update on Dragon Silk Production Utilizing the BAM-1 Platform
Ann Arbor, Michigan--(Newsfile Corp. - May 28, 2024) - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs")... 
Via Newsfile
Kraig Biocraft Laboratories Prepares to Accelerate Production Launch following Spring Trials Success
Ann Arbor, Michigan--(Newsfile Corp. - May 20, 2024) - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"),... 
Via Newsfile

Performance

YTD
+147.33%
+147.33%
1 Month
+0.22%
+0.22%
3 Month
-38.00%
-38.00%
6 Month
-0.54%
-0.54%
1 Year
+143.42%
+143.42%

More News

Read More
Kraig Biocraft Laboratories Provides a Statement on the Market Response to Recent Company Milestones and Shareholder Communications
Via Newsfile
24/7 Market News Publishes Report on Recent Spider Silk Production Breakthroughs Featuring Kraig Biocraft Laboratories
Via Newsfile
Kraig Biocraft Laboratories Spring Production Trials Exceed Expectations for the Production of the Company's Recombinant Spider Silk
Via Newsfile
Short Volatility Alert: Kraig Biocraft Laboratories, Inc.
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.